Cargando…
Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys
BACKGROUND: The Global Programme to Eliminate Lymphatic Filariasis has encouraged countries to follow a set of guidelines to help them assess the need for mass drug administration and evaluate its progress. Papua New Guinea (PNG) is one of the highest priority countries in the Western Pacific for ly...
Autores principales: | Berg Soto, Alvaro, Xu, Zhijing, Wood, Peter, Sanuku, Nelly, Robinson, Leanne J., King, Christopher L., Tisch, Daniel, Susapu, Melinda, Graves, Patricia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280391/ https://www.ncbi.nlm.nih.gov/pubmed/30533996 http://dx.doi.org/10.1186/s41182-018-0123-8 |
Ejemplares similares
-
An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys
por: Cano, Jorge, et al.
Publicado: (2015) -
Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
por: Stolk, Wilma A., et al.
Publicado: (2022) -
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011
por: Graves, Patricia M, et al.
Publicado: (2013) -
Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011) -
The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea
por: Weil, Gary J., et al.
Publicado: (2008)